SCHEMBL10143767

SCHEMBL10143767

COc1ccc(Nc2nc(Cl)nc(N3CCN(C(=O)OC(C)(C)C)CC3)n2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.67
MEN1 O00255 3/20 0.67
KMT2A Q03164 3/20 0.67
MAPK1 P28482 3/20 0.67
TDP1 Q9NUW8 2/20 0.67
L3MBTL1 Q9Y468 2/20 0.67
SMN1; SMN2 Q16637 5/20 0.59
HTT P42858 1/20 0.59
GALR2 O43603 1/20 0.54
GALR1 P47211 1/20 0.54
ALDH1A1 P00352 2/20 0.53
APP P05067 1/20 0.52
CCNK O75909 1/20 0.48
CCNA2 P20248 1/20 0.48
CDK2 P24941 1/20 0.48
CCND3 P30281 1/20 0.48
CDK9 P50750 1/20 0.48
CDK6 Q00534 1/20 0.48
GBA1 P04062 1/20 0.48
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30675103 0.85 GALR2 (0.48) MAPTMEN1KMT2AMAPK1TDP1
SCHEMBL10143436 0.83 GALR2 (0.64) MAPTMEN1KMT2AMAPK1TDP1
SCHEMBL10143493 0.83 GALR1 (0.74) MAPTMEN1KMT2AMAPK1TDP1
SCHEMBL10143663 0.82 GALR2 (0.51) MAPTMEN1KMT2AMAPK1TDP1
SCHEMBL6234182 0.82 MAPT (0.53) MAPTKMT2ASMN1; SMN2HTTALDH1A1
SCHEMBL30675091 0.82 GALR2 (0.46) MAPTMEN1KMT2AMAPK1TDP1
SCHEMBL15879042 0.79 MEN1 (0.50) MAPTMEN1KMT2ASMN1; SMN2HTT
SCHEMBL1409174 0.79 GPR119 (0.49) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL14387482 0.79 MEN1 (0.50) MAPTMEN1KMT2ASMN1; SMN2HTT
SCHEMBL17630268 0.76 CCND3 (0.63) MAPTMEN1KMT2ASMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009258-A2 PEPTIDOMIMETIC GALANIN RECEPTOR MODULATORS ROBERTS EDWARD (US) 2012-01-19 WO disclosed